DISRUPT PAD III results and how they fit into the endovascular war against severe calcification


Moderate-to-severe calcification in peripheral arteries is an “ongoing battle” in in the endovascular treatment of complex lesions, William Gray (Philadelphia, USA), tells Vascular News.

Gray explains that there are a number of tools deployed to win the acute battle, but notes frankly that they have never been tested meaningfully in a randomised setting. In the longer-term patency war, when drug-coated balloons are employed as treatment options, interventionalists could use some “reinforcements”. he says.

It is in this context that the acute 30-days results from the DISRUPT PAD III data, billed as the largest-ever randomised clinical trial of severely calcified peripheral lesions, demonstrate superior outcomes with the use of intravascular lithotripsy (Shockwave) over percutaneous transluminal angioplasty.


Please enter your comment!
Please enter your name here